D&MD’s Organic and Medicinal Chemistry in Drug Discovery Report analyzes the methods and technologies currently used to craft compound collections as well as the products and services available in support of pharma’s chemistry programs. This Report critically evaluates both existing and emerging technologies for organic synthesis and compound design. In addition, the technology and market trends in organic and medicinal chemistry for drug discovery are discussed in depth, and current sales and market projections for outsourcing products and services are also provided. This Report offers the views of key industry participants on the state of and future prospects for organic and medicinal chemistry in drug discovery. This data was obtained through a proprietary market survey conducted by D&MD publications In addition to the survey, in-depth interviews were conducted with chemists and managers in pharma, biopharma, and vendor organizations. The inclusion of the history and evolution of organic and medicinal chemistry in pharma provides perspective on current approaches and future directions.
(0 items)
